Chest:肺癌患者的咳嗽:特征和临床关联的纵向观察性研究

2018-10-15 xiangting MedSci原创

这是首个描述肺癌患者咳嗽特征的研究,确定了可能与其治疗相关的临床相关性。

咳嗽在肺癌患者中很常见,目前的镇咳治疗不是太理想。已发布的描述肺癌患者咳嗽的数据或评估其临床关联的工作很少;这一研究的目的是填补这一空白。

这是一项超过60天的纵向前瞻性、观察性单队列研究。通过自我报告的验证量表评估患者,并在子样本中,在研究开始(第0天)、第30天和第60天进行动态咳嗽监测。

研究开始时,纳入了177名患者,其中153名患者在第60天提供了数据。咳嗽的中位持续时间为52周(IQR 8.5-260)。62%患者的咳嗽被描述为严重到需要治疗。根据使用的量表,表现状态与研究开始时咳嗽严重程度和咳嗽的影响相关(p<0.001),而研究开始时较重的咳嗽严重程度与女性(p=0.02)、哮喘(p=0.035)和反流病相关(p<0.001);研究开始时的咳嗽影响还与出现恶心相关(p=0.018)。癌症特征(即癌症分期、组织学)与咳嗽严重程度或咳嗽影响无关;吸烟或COPD也与咳嗽严重程度或咳嗽影响无关。

这是首个描述肺癌患者咳嗽特征的研究,确定了可能与其治疗相关的临床相关性。这项研究数据表明,咳嗽是一种常见且令人痛苦的症状,并且临床需求未得到满足。这项研究中它与肠症状的相关性可以提高人们对肺癌患者咳嗽病理生理学和治疗选择的理解。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1990662, encodeId=39b7199066227, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Feb 03 01:29:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051261, encodeId=6624205126144, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Nov 07 07:29:00 CST 2018, time=2018-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929522, encodeId=5510192952229, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Thu May 02 14:29:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499818, encodeId=4d791499818b4, content=<a href='/topic/show?id=113c90584e6' target=_blank style='color:#2F92EE;'>#观察性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90584, encryptionId=113c90584e6, topicName=观察性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34519379140, createdName=shock_melon, createdTime=Wed Oct 17 07:29:00 CST 2018, time=2018-10-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1990662, encodeId=39b7199066227, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Feb 03 01:29:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051261, encodeId=6624205126144, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Nov 07 07:29:00 CST 2018, time=2018-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929522, encodeId=5510192952229, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Thu May 02 14:29:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499818, encodeId=4d791499818b4, content=<a href='/topic/show?id=113c90584e6' target=_blank style='color:#2F92EE;'>#观察性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90584, encryptionId=113c90584e6, topicName=观察性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34519379140, createdName=shock_melon, createdTime=Wed Oct 17 07:29:00 CST 2018, time=2018-10-17, status=1, ipAttribution=)]
    2018-11-07 xiangyuzhou971
  3. [GetPortalCommentsPageByObjectIdResponse(id=1990662, encodeId=39b7199066227, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Feb 03 01:29:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051261, encodeId=6624205126144, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Nov 07 07:29:00 CST 2018, time=2018-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929522, encodeId=5510192952229, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Thu May 02 14:29:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499818, encodeId=4d791499818b4, content=<a href='/topic/show?id=113c90584e6' target=_blank style='color:#2F92EE;'>#观察性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90584, encryptionId=113c90584e6, topicName=观察性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34519379140, createdName=shock_melon, createdTime=Wed Oct 17 07:29:00 CST 2018, time=2018-10-17, status=1, ipAttribution=)]
    2019-05-02 Smile2680
  4. [GetPortalCommentsPageByObjectIdResponse(id=1990662, encodeId=39b7199066227, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Feb 03 01:29:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051261, encodeId=6624205126144, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Nov 07 07:29:00 CST 2018, time=2018-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929522, encodeId=5510192952229, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Thu May 02 14:29:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499818, encodeId=4d791499818b4, content=<a href='/topic/show?id=113c90584e6' target=_blank style='color:#2F92EE;'>#观察性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90584, encryptionId=113c90584e6, topicName=观察性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34519379140, createdName=shock_melon, createdTime=Wed Oct 17 07:29:00 CST 2018, time=2018-10-17, status=1, ipAttribution=)]

相关资讯

咳嗽、气促看似肺病 实则是软骨病!

患者男性,70岁,因“反复咳嗽、气促4年,加重5天”于2008年3月21日入院。

每日咳痰20斤,这是什么病?

超级大量咳痰的诊断和鉴别诊断!

NEJM:播散性放线菌病-病例报道

该患者被诊断为播散性放线菌病,这是一种由放线菌引起的罕见、缓慢进展的细菌感染,可表现为感染组织中多个脓肿和含硫颗粒的形成。

2018 CHEST指南:间质性肺病相关性咳嗽的治疗

间质性肺部引起的慢性咳嗽严重影像患者的生活质量,需要有效的治疗手段,本文主要针对咳嗽的管理和治疗提供指南建议。

NEJM:口哨音咳嗽-病例报道

虽然无法明确识别异物,但是在呼气末X射线照片中见空气滞留可以表明在支气管中存在吸入的异物,因为空气可以进入异物周围的支气管但不能排出。